Diagnostic Algorithm to Subclassify Atypical Spitzoid Tumors in Low and High Risk According to Their Methylation...

Area of Science:

• Dermatopathology
• Epigenetics
• Genomics

Background:

• Current diagnostic methods for cutaneous spitzoid tumors, especially atypical spitzoid tumors (AST), are inadequate for precise clinical and therapeutic decisions.
• There is a critical need for reliable biomarkers to assess malignancy potential and guide individualized treatment strategies.

Purpose of the Study:

• To identify novel genome-wide methylation markers for improved diagnosis and risk stratification of Spitz nevi (SN), spitzoid melanoma (SM), and AST.
• To develop a predictive epigenetic algorithm for assessing the malignant potential of AST.

Main Methods:

• Genome-wide methylation profiling using Reduced Representation Bisulfite Sequencing (RRBS) on a cohort of SN, SM, and AST.
• Development of a diagnostic algorithm based on the methylation status of seven specific cg sites.

Main Results:

• An epigenetic algorithm was established using methylation data from seven cg sites in TETK4P2, MYO1D, and PMF1-BGLAP.
• The algorithm successfully differentiates between SN and SM.
• The algorithm effectively subclasses AST based on methylation similarity to SN or SM, predicting risk and clinical outcomes.

Conclusions:

• The developed epigenetic algorithm provides a reliable and reproducible method for diagnosing and subclassifying cutaneous spitzoid tumors.
• This tool aids in predicting the individual malignant potential of AST, enabling tailored therapeutic approaches.
• Epigenetic profiling offers a promising avenue for advancing the management of spitzoid neoplasms.